236 related articles for article (PubMed ID: 10795369)
1. Familial defective apolipoprotein B-100 (R3500Q) in Northern Ireland.
McClean E; Graham CA; Ward AJ; Young IS; Martin S; Nicholls DP
Br J Biomed Sci; 1999; 56(4):258-62. PubMed ID: 10795369
[TBL] [Abstract][Full Text] [Related]
2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
3. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
Defesche JC; Pricker KL; Hayden MR; van der Ende BE; Kastelein JJ
Arch Intern Med; 1993 Oct; 153(20):2349-56. PubMed ID: 8215738
[TBL] [Abstract][Full Text] [Related]
4. Familial defective apolipoprotein B-100.
Hansen PS
Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
[TBL] [Abstract][Full Text] [Related]
5. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
[TBL] [Abstract][Full Text] [Related]
6. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations.
Dedoussis GV; Skoumas J; Pitsavos C; Choumerianou DM; Genschel J; Schmidt H; Stefanadis C
Eur J Clin Invest; 2004 Jun; 34(6):402-9. PubMed ID: 15200491
[TBL] [Abstract][Full Text] [Related]
7. High-resolution melting analysis for detection of familial ligand-defective apolipoprotein B-100 mutations.
Liyanage KE; Hooper AJ; Defesche JC; Burnett JR; van Bockxmeer FM
Ann Clin Biochem; 2008 Mar; 45(Pt 2):170-6. PubMed ID: 18325181
[TBL] [Abstract][Full Text] [Related]
8. Genetic causes of familial hypercholesterolaemia in a Malaysian population.
Khoo KL; Van Acker P; Tan H; Deslypere JP
Med J Malaysia; 2000 Dec; 55(4):409-18. PubMed ID: 11221151
[TBL] [Abstract][Full Text] [Related]
9. Familial defective apolipoprotein B-100: molecular basis, prevalence and clinical features.
Friedl W
Wien Klin Wochenschr; 1991; 103(20):621-5. PubMed ID: 1763509
[TBL] [Abstract][Full Text] [Related]
10. Familial ligand-defective apolipoprotein B-100: simultaneous detection of the ARG3500-->GLN and ARG3531-->CYS mutations in a French population.
Rabès JP; Varret M; Saint-Jore B; Erlich D; Jondeau G; Krempf M; Giraudet P; Junien C; Boileau C
Hum Mutat; 1997; 10(2):160-3. PubMed ID: 9259199
[TBL] [Abstract][Full Text] [Related]
11. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.
Real JT; Chaves FJ; Ejarque I; García-García AB; Valldecabres C; Ascaso JF; Armengod ME; Carmena R
Eur J Hum Genet; 2003 Dec; 11(12):959-65. PubMed ID: 14508510
[TBL] [Abstract][Full Text] [Related]
12. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia.
Myant NB
Atherosclerosis; 1993 Dec; 104(1-2):1-18. PubMed ID: 8141833
[TBL] [Abstract][Full Text] [Related]
13. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ
Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
[TBL] [Abstract][Full Text] [Related]
14. [Familial defect of apo B-100 in subjects with clinically diagnosed primary hypercholesterolemia: identification of the first family with this disorder in Spain].
Real JT; Chaves JF; Ascaso JF; Armengod ME; Carmena R
Med Clin (Barc); 1999 Jun; 113(1):15-7. PubMed ID: 10422071
[TBL] [Abstract][Full Text] [Related]
15. [Identification and characterization of the first Spanish familial ligand-defective apolipoprotein B homozygote].
Ejarque I; Civer M; Francisco Ascaso J; Knecht E; Eugenia Armengod M; Carmen R; Tomás Real J; Francisco Chaves J; Javier Martín De Llano J
Med Clin (Barc); 2001 Feb; 116(4):138-41. PubMed ID: 11222161
[TBL] [Abstract][Full Text] [Related]
16. [Screening for mutations in apolipoprotein B genes in a group of patients with hyperlipoproteinemia].
Grombiríková H; Freiberger T; Kuhrová V; Soska V; Nedomová K
Cas Lek Cesk; 2001 Jan; 140(1):18-21. PubMed ID: 11242979
[TBL] [Abstract][Full Text] [Related]
17. Familial ligand-defective apolipoprotein B-100: detection, biochemical features and haplotype analysis of the R3531C mutation in the UK.
Wenham PR; Henderson BG; Penney MD; Ashby JP; Rae PW; Walker SW
Atherosclerosis; 1997 Mar; 129(2):185-92. PubMed ID: 9105560
[TBL] [Abstract][Full Text] [Related]
18. Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
Pimstone SN; Defesche JC; Clee SM; Bakker HD; Hayden MR; Kastelein JJ
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):826-33. PubMed ID: 9157944
[TBL] [Abstract][Full Text] [Related]
19. Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familial defective ApoB.
van der Hoek YY; Lingenhel A; Kraft HG; Defesche JC; Kastelein JJ; Utermann G
J Clin Invest; 1997 May; 99(9):2269-73. PubMed ID: 9151801
[TBL] [Abstract][Full Text] [Related]
20. Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.
Raal FJ; Pilcher G; Rubinsztein DC; Lingenhel A; Utermann G
Atherosclerosis; 1997 Feb; 129(1):97-102. PubMed ID: 9069523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
